Visa Inc. · V · FY2026 Q2 · Calendar Q2 2026
Visa Beats on Revenue and EPS, Raises Guidance on VAS Strength and Stablecoin Expansion
Visa delivered its strongest top-line growth since 2022 in Q2 FY2026, with revenue of $11.2 billion (+17% YoY) and EPS of $3.31, beating consensus estimates by 4.5% on revenue and 6.8% on EPS. Value-added services now represent approximately 30% of net revenue and grew 27% YoY, reflecting a structural shift beyond transaction processing toward higher-margin recurring services. Management raised full-year guidance to low-double-digit revenue growth and low-teen EPS growth, supported by a record $7.9 billion share repurchase authorization. Emerging growth engines — AI-driven agentic commerce (Visa CLI, Intelligent Commerce Connect) and stablecoin settlement infrastructure ($7 billion annualized run rate across six blockchains) — position Visa for incremental multi-billion-dollar opportunities beyond its core payments network. The stock responded with an 8.3% abnormal move on the…
Company context
Snapshot as of publicationVisa Inc. functions globally as a leading technology company dedicated to payments. Its primary role is to enable the secure and efficient digital transfer of funds among a wide array of participants, including individual consumers, retail businesses, banking institutions, corporations, strategic partners, and governmental bodies. At the heart of its operations is VisaNet, a highly sophisticated transaction processing network that handles the critical functions of authorizing, clearing, and settling all payment transactions.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Aug 31, 2026 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 25, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 5, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 3, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 30, 2026 |
| UBS | Buy | Buy | Maintain | Jul 29, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 29, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 29, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Macquarie | Outperform | Outperform | Maintain | Apr 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 29, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 29, 2026 |
| Freedom Capital Markets | Buy | Hold | Upgrade | Feb 17, 2026 |
| Freedom Broker | Buy | Hold | Upgrade | Feb 17, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 30, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Dec 11, 2025 |
| HSBC | Buy | Hold | Upgrade | Dec 8, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 29, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jul 31, 2025 |
| Mizuho | Outperform | Neutral | Upgrade | Jun 5, 2025 |
| Jefferies | Buy | Buy | Maintain | May 27, 2025 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jan 31, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 31, 2025 |
| Seaport Global | Buy | Neutral | Upgrade | Jan 14, 2025 |
| TD Cowen | Buy | Buy | Maintain | Oct 30, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 30, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Apr 24, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Mar 27, 2024 |
| Keybanc | Overweight | Overweight | Maintain | Jan 8, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Bernstein | Outperform | Outperform | Maintain | Apr 19, 2023 |
| Daiwa Capital | Neutral | Outperform | Downgrade | Aug 12, 2021 |
| Stephens & Co. | Overweight | Overweight | Maintain | May 4, 2021 |
| Cowen & Co. | Outperform | Outperform | Maintain | May 20, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 1, 2020 |
| Nomura | Buy | Buy | Maintain | Apr 9, 2020 |
| Bank of America | Buy | Buy | Maintain | Aug 13, 2018 |
| Buckingham Research | Buy | Buy | Maintain | Jun 26, 2018 |
| Buckingham | Buy | Buy | Maintain | Jun 26, 2018 |
| Argus Research | Buy | Buy | Maintain | Apr 27, 2018 |
| Argus | Buy | Buy | Maintain | Apr 27, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Feb 2, 2018 |
| DZ Bank | Hold | Buy | Downgrade | Jan 24, 2018 |
| Loop Capital | Buy | Buy | Maintain | Oct 26, 2017 |
| Guggenheim | Buy | Neutral | Upgrade | Dec 5, 2016 |
| Drexel Hamilton | Hold | Hold | Maintain | Oct 24, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Dec 8, 2015 |
| Pacific Crest | Overweight | Overweight | Maintain | Nov 3, 2015 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 30, 2015 |
| Stifel | Buy | Buy | Maintain | Jan 30, 2015 |
| FBR Capital | Market Perform | Outperform | Downgrade | Jan 30, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Nov 11, 2014 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Apr 15, 2014 |
| Janney Capital | Buy | Neutral | Upgrade | Apr 15, 2014 |
| Argus Capital | Hold | Buy | Downgrade | Mar 1, 2013 |
| Meredith Whitney Advisory Group | Outperform | Outperform | Maintain | May 3, 2012 |
| Canaccord Genuity | Neutral | Neutral | Maintain | May 3, 2012 |
| Morgan Keegan | Outperform | Outperform | Maintain | Feb 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $370.45. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Daniel Perlin | $466 | $381.6 | +25.8% | Aug 31, 2026 |
| Wolfe Research | Analyst unavailable | $460 | $382.41 | +24.2% | Aug 25, 2026 |
| Truist Financial | Analyst unavailable | $406 | $370.42 | +9.6% | Aug 5, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $445 | $370.38 | +20.1% | Aug 3, 2026 |
| Wells Fargo | Jason Kupferberg | $432 | $368.73 | +16.6% | Jul 30, 2026 |
| Cantor Fitzgerald | Ramsey El-Assal | $410 | $371.14 | +10.7% | Jul 29, 2026 |
| RBC Capital | Analyst unavailable | $412 | $368.1 | +11.2% | Jul 29, 2026 |
| BMO Capital | Analyst unavailable | $405 | $367.17 | +9.3% | Jul 29, 2026 |
| Piper Sandler | Bill Carcache | $430 | $366.59 | +16.1% | Jul 29, 2026 |
| Susquehanna | Analyst unavailable | $427 | $366.59 | +15.3% | Jul 29, 2026 |
| UBS | Analyst unavailable | $420 | $366.59 | +13.4% | Jul 29, 2026 |
| Wolfe Research | Darrin Peller | $435 | $366.59 | +17.4% | Jul 29, 2026 |
| Morgan Stanley | James Faucette | $416 | $366.59 | +12.3% | Jul 29, 2026 |
| Raymond James | Madison Suhr | $406 | $366.59 | +9.6% | Jul 29, 2026 |
| Deutsche Bank | Nate Svensson | $430 | $366.59 | +16.1% | Jul 29, 2026 |
| Truist Financial | Analyst unavailable | $394 | $351.6 | +6.4% | Jul 24, 2026 |
| BMO Capital | Analyst unavailable | $387 | $356.84 | +4.5% | Jul 15, 2026 |
| Barclays | Nik Cremo | $420 | $352.2 | +13.4% | Jul 8, 2026 |
| Robert W. Baird | Analyst unavailable | $412 | $357.25 | +11.2% | Jul 6, 2026 |
| Piper Sandler | Analyst unavailable | $394 | $341.65 | +6.4% | Jun 29, 2026 |
| Bernstein | Harshita Rawat | $450 | $317.99 | +21.5% | Jun 2, 2026 |
| Truist Financial | Matthew Coad | $371 | $323.86 | +0.1% | May 12, 2026 |
| Raymond James | Analyst unavailable | $389 | $336.19 | +5.0% | Apr 29, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $335.12 | -5.5% | Apr 29, 2026 |
| Oppenheimer | Analyst unavailable | $403 | $336.88 | +8.8% | Apr 29, 2026 |
| Morgan Stanley | Analyst unavailable | $415 | $334.37 | +12.0% | Apr 29, 2026 |
| Truist Financial | Analyst unavailable | $361 | $306.68 | -2.6% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $365 | $309.94 | -1.5% | Apr 21, 2026 |
| Truist Financial | Matthew Coad | $372 | $328.74 | +0.4% | Feb 10, 2026 |
| Daiwa | Analyst unavailable | $370 | $333.84 | -0.1% | Feb 2, 2026 |
| Morgan Stanley | Analyst unavailable | $411 | $331.8 | +10.9% | Jan 30, 2026 |
| Piper Sandler | Analyst unavailable | $160 | $325.26 | -56.8% | Jan 28, 2026 |
| Redburn Partners | Analyst unavailable | $385 | $325.26 | +3.9% | Jan 28, 2026 |
| Cantor Fitzgerald | Ramsey El-Assal | $400 | $328.49 | +8.0% | Jan 26, 2026 |
| Truist Financial | Analyst unavailable | $374 | $326.43 | +1.0% | Jan 20, 2026 |
| Evercore ISI | Analyst unavailable | $380 | $345.65 | +2.6% | Dec 12, 2025 |
| HSBC | Saul Martinez | $389 | $331.24 | +5.0% | Dec 7, 2025 |
| UBS | Analyst unavailable | $425 | $346.9 | +14.7% | Oct 29, 2025 |
| Robert W. Baird | Analyst unavailable | $425 | $346.9 | +14.7% | Oct 29, 2025 |
| Morgan Stanley | James Faucette | $398 | $349.5 | +7.4% | Oct 29, 2025 |
| KeyBanc | Andrew Schmidt | $405 | $347.21 | +9.3% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $412 | $347.21 | +11.2% | Oct 21, 2025 |
| Robert W. Baird | David Koning | $410 | $349.84 | +10.7% | Oct 6, 2025 |
| Barclays | Ramsey El-Assal | $408 | $350.91 | +10.1% | Jul 31, 2025 |
| UBS | Analyst unavailable | $415 | $350.91 | +12.0% | Jul 30, 2025 |
| Mizuho Securities | Dan Dolev | $425 | $366.77 | +14.7% | Jun 5, 2025 |
| Truist Financial | Matthew Coad | $400 | $363.13 | +8.0% | Jun 2, 2025 |
| Barclays | Ramsey El-Assal | $361 | $311.67 | -2.6% | Jan 14, 2025 |
| Morgan Stanley | James Faucette | $371 | $309.78 | +0.1% | Dec 18, 2024 |
| Susquehanna | James Friedman | $375 | $313.79 | +1.2% | Dec 11, 2024 |
| Macquarie | Paul Golding | $335 | $290.16 | -9.6% | Oct 30, 2024 |
| Piper Sandler | Arvind Ramnani | $322 | $281.88 | -13.1% | Oct 30, 2024 |
| Deutsche Bank | Bryan Keane | $340 | $281.88 | -8.2% | Oct 30, 2024 |
| Citigroup | Ashwin Shirvaikar | $326 | $281.88 | -12.0% | Oct 30, 2024 |
| Robert W. Baird | David Koning | $330 | $287.52 | -10.9% | Oct 17, 2024 |
| Williams Trading | Trevor Williams | $320 | $277.84 | -13.6% | Oct 14, 2024 |
| Oppenheimer | Rayna Kumar | $318 | $274.95 | -14.2% | Sep 30, 2024 |
| Citigroup | Andrew Schmidt | $319 | $288.63 | -13.9% | Sep 24, 2024 |
| Compass Point | Dominick Gabriele | $319 | $278.54 | -13.9% | Sep 4, 2024 |
| BNP Paribas | Alexandre Faure | $325 | $276.37 | -12.3% | Sep 3, 2024 |
| RBC Capital | Daniel Perlin | $315 | $254.92 | -15.0% | Jul 24, 2024 |
| Piper Sandler | Arvind Ramnani | $319 | $264.79 | -13.9% | Jul 24, 2024 |
| Barclays | Ramsey El-Assal | $319 | $272.46 | -13.9% | Jun 3, 2024 |
| BMO Capital | Rufus Hone | $300 | $279.84 | -19.0% | May 17, 2024 |
| Bernstein | Harshita Rawat | $310 | $275.02 | -16.3% | Apr 25, 2024 |
| Goldman Sachs | Will Nance | $335 | $276.02 | -9.6% | Apr 24, 2024 |
| Macquarie | Paul Golding | $300 | $275.95 | -19.0% | Apr 24, 2024 |
| Robert W. Baird | David Koning | $320 | $271.35 | -13.6% | Apr 17, 2024 |
| Oppenheimer | Dominick Gabriele | $297 | $274.98 | -19.8% | Feb 12, 2024 |
| Oppenheimer | Chris Kotowski | $243 | $259.16 | -34.4% | Dec 27, 2023 |
| Wedbush | Nick Setyan | $275 | $241.2 | -25.8% | Oct 18, 2023 |
| RBC Capital | Daniel Perlin | $290 | $237.1 | -21.7% | Jul 26, 2023 |
| Morgan Stanley | James Faucette | $290 | $241.77 | -21.7% | Jul 19, 2023 |
| Citigroup | Ashwin Shirvaikar | $270 | $232.76 | -27.1% | Apr 25, 2023 |
| UBS | Analyst unavailable | $287 | $207.91 | -22.5% | Dec 15, 2022 |
| Wells Fargo | Analyst unavailable | $250 | $215.34 | -32.5% | Dec 2, 2022 |
| Mizuho Securities | Dan Dolev | $220 | $206.92 | -40.6% | Nov 1, 2022 |
| Credit Suisse | Moshe Orenbuch | $245 | $203.35 | -33.9% | Oct 26, 2022 |
| Morgan Stanley | Analyst unavailable | $282 | $180.75 | -23.9% | Oct 3, 2022 |
| BMO Capital | Analyst unavailable | $257 | $210.47 | -30.6% | Jul 28, 2022 |
| Barclays | Analyst unavailable | $271 | $210.47 | -26.8% | Jul 28, 2022 |
| Raymond James | Analyst unavailable | $262 | $210.47 | -29.3% | Jul 28, 2022 |
| Morgan Stanley | Analyst unavailable | $291 | $215.68 | -21.4% | Jul 27, 2022 |
| UBS | Analyst unavailable | $296 | $212.49 | -20.1% | Jul 27, 2022 |
| Macquarie | Analyst unavailable | $260 | $212.49 | -29.8% | Jul 27, 2022 |
| Oppenheimer | Analyst unavailable | $242 | $213.7 | -34.7% | Jul 25, 2022 |
| Robert W. Baird | David Koning | $265 | $213.66 | -28.5% | Jul 20, 2022 |
| Wells Fargo | Analyst unavailable | $255 | $200.79 | -31.2% | Jul 13, 2022 |
| Piper Sandler | Analyst unavailable | $204 | $200.54 | -44.9% | Jul 6, 2022 |
| Mizuho Securities | Analyst unavailable | $215 | $195.32 | -42.0% | Jul 1, 2022 |
| Evercore ISI | David Togut | $310 | $190.69 | -16.3% | May 12, 2022 |
| Barclays | Analyst unavailable | $263 | $208.06 | -29.0% | May 2, 2022 |
| Robert W. Baird | David Koning | $290 | $208.49 | -21.7% | May 2, 2022 |
| Morgan Stanley | James Faucette | $284 | $216.11 | -23.3% | Apr 27, 2022 |
| Credit Suisse | Analyst unavailable | $265 | $218.37 | -28.5% | Apr 27, 2022 |
| Citigroup | Ashwin Shirvaikar | $265 | $209.95 | -28.5% | Apr 25, 2022 |
| Morgan Stanley | Analyst unavailable | $279 | $217.79 | -24.7% | Apr 21, 2022 |
| Wells Fargo | Donald Fandetti | $280 | $212.79 | -24.4% | Apr 15, 2022 |
| Barclays | Ramsey El-Assal | $260 | $226.09 | -29.8% | Apr 5, 2022 |
| UBS | Rayna Kumar | $303 | $222.69 | -18.2% | Feb 21, 2022 |
| Mizuho Securities | Dan Dolev | $235 | $228.39 | -36.6% | Feb 6, 2022 |
| Wedbush | Moshe Katri | $270 | $227.63 | -27.1% | Jan 28, 2022 |
| BMO Capital | James Fotheringham | $247 | $227.63 | -33.3% | Jan 28, 2022 |
| Susquehanna | James Friedman | $290 | $227.63 | -21.7% | Jan 28, 2022 |
| Piper Sandler | Christopher Donat | $283 | $227.63 | -23.6% | Jan 28, 2022 |
| Raymond James | John Davis | $281 | $227.63 | -24.1% | Jan 28, 2022 |
| Evercore ISI | David Togut | $312 | $227.63 | -15.8% | Jan 28, 2022 |
| BNP Paribas | Alexandre Faure | $210 | $211.62 | -43.3% | Jan 10, 2022 |
| Citigroup | Ashwin Shirvaikar | $285 | $209.13 | -23.1% | Oct 28, 2021 |
| Bank of America Securities | Jason Kupferberg | $279 | $227.54 | -24.7% | Sep 23, 2021 |
| Credit Suisse | Moshe Orenbuch | $285 | $224.35 | -23.1% | Sep 3, 2021 |
| Daiwa | Kazuya Nishimura | $250 | $231.01 | -32.5% | Aug 12, 2021 |
| Compass Point | Michael Del Grosso | $290 | $245.77 | -21.7% | Jul 28, 2021 |
| Truist Financial | Andrew Jeffrey | $275 | $245.77 | -25.8% | Jul 28, 2021 |
| Goldman Sachs | Matthew O’Neill | $264 | $241.55 | -28.7% | Jul 20, 2021 |
| Oppenheimer | Dominick Gabriele | $281 | $237.34 | -24.1% | Jul 9, 2021 |
| Stephens | Brett Huff | $259 | $230.6 | -30.1% | May 4, 2021 |
| Argus Research | Stephen Biggar | $270 | $235.4 | -27.1% | Apr 29, 2021 |
| MoffettNathanson | Lisa Elis | $270 | $232.01 | -27.1% | Apr 28, 2021 |
Track every rating change on V the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session closeFollow V with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue growth accelerated from 15% YoY in Q1 to 17% YoY in Q2 FY2026, the strongest top-line growth since 2022. Guidance was raised from maintained to low-double-digit revenue growth and low-teen EPS growth for FY2026. Stablecoin settlement annualized run rate grew from $4.6 billion in Q1 to $7 billion in Q2, with five new blockchains added: Arc, Base, Canton, Polygon, and Tempo. Value-added services reached approximately 30% of net revenue, growing 27% YoY. Visa launched a proof-of-concept Visa CLI tool for command-line developer payments and became a validator on Tempo blockchain and a super validator on the Canton network. A record $7.9 billion share repurchase was announced. New partnerships include TikTok (Creator Card), PayPay (Japan), X (Money), UnionPay International (Moneyexpress), Westpac, Scotiabank, Highnote, and Wells Fargo (Pismo migration).
Guidance delta
Visa raised full-year FY2026 guidance from the prior quarter's maintained stance. Management now projects low-double-digit revenue growth and low-teen EPS growth, compared with the prior quarter's unchanged low-double-digit adjusted revenue growth outlook. The raised outlook reflects stronger-than-expected value-added services growth, commercial solutions momentum, and cross-border volume strength. In Q1, guidance sentiment was characterized as maintained; in Q2, it shifted to raised.
Key takeaways
- Revenue and EPS beat expectations, with the strongest top-line growth since 2022.
- Value-added services now represent about 30% of net revenue, growing 27% YoY.
- AI-driven agentic commerce and stablecoin initiatives are positioned as future multi-billion-dollar growth engines.
- Guidance raised to low-double-digit revenue growth and low-teen EPS growth for FY2026.
- Record $7.9 billion share repurchase underscored strong capital allocation confidence.
Management priorities
- Scale Visa CLI and Intelligent Commerce Connect for broader agentic commerce adoption.
- Launch additional stablecoin-linked card programs and expand settlement on new blockchains.
- Deepen Visa Direct integrations (e.g., X Money, UnionPay Moneyexpress).
- Continue rollout of AI-powered fraud and risk models, including the Visa Large Transaction Model.
- Leverage Pismo platform to win more large-bank modernization deals.
Related earnings events
Financial ServicesSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-28T06:22:17.099518+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T06:22:17.095484+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.